why choose us

First received: July 08, 2022

Clinical Trial: Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Uterine Cervix Cancer

Study Type: INTERVENTIONAL


Official Title: Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer

Brief Summary: This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer.Women receive standard-of-care radiochemotherapy followed by brachytherapy.Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.

Read more